Furthermore, IBD represents a risk factor for the development of colorectal cancer, and inflammation-associated estrogen receptor dysregulation might be one of the factors linking chronic intestinal diseases to neoplastic transformation. Here, ESR1 is linked to inflammatory bowel disease.